OptimizeRx (OPRX) Other financing activities (2010 - 2025)

OptimizeRx (OPRX) posted Other financing activities of $14000.0 for Q4 2025, up 1300.0% sequentially from $1000.0 in Q3 2023.

OptimizeRx (OPRX) Other financing activities (2010 - 2025) Analysis & Trends

OptimizeRx has reported Other financing activities for 8 years, with the latest figure at $14000.0 in Q4 2025.

Quarterly Other financing activities changed N/A year-over-year to $14000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $120000.0 (down 17.81% YoY) and the FY2025 annual result came in at $352000.0, changed N/A from the prior year.
Other financing activities grew to $14000.0 in Q4 2025 per OPRX's latest filing, from $1000.0 in the prior quarter.
Over five years, Other financing activities peaked at $1.6 million in Q2 2021 and troughed at $1000.0 in Q3 2023.
A 4-year average of $508142.7 and a median of $238879.0 in 2022 frame the typical range for Other financing activities.
The sharpest annual moves came in 2021 and 2023: Other financing activities jumped 898.65% in 2021, then plunged 99.54% in 2023.
Over 4 years, Other financing activities stood at $1.1 million in 2021, then plunged by 97.79% to $23377.0 in 2022, then slumped by 95.72% to $1000.0 in 2023, then surged by 1300.0% to $14000.0 in 2025.
According to Business Quant data, Other financing activities over the past three periods registered $14000.0, $1000.0, and $105000.0 for Q4 2025, Q3 2023, and Q2 2023 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Veeva Systems	39.72 Bn	32.40 Bn	662.02 Mn
2	BrightSpring Health Services	12.19 Bn	11.64 Bn	492.75 Mn
3	Healthequity	8.79 Bn	8.52 Bn	256.31 Mn
4	10x Genomics	7.31 Bn	6.76 Bn	112.50 Mn
5	Hinge Health	7.10 Bn	6.71 Bn	183.95 Mn
6	MiniMed	5.66 Bn	5.36 Bn	480.00 Mn
7	Waystar Holding	4.76 Bn	4.56 Bn	221.99 Mn
8	Doximity	4.46 Bn	3.77 Bn	132.93 Mn
9	Heartflow	3.66 Bn	3.28 Bn	53.19 Mn
10	OptimizeRx	164.25 Mn	140.15 Mn	15.69 Mn

Download Data